采用批处理-微流控混合方法制备具有增强单分散性和封装效率的多腔PLGA微颗粒

IF 4 Q2 ENGINEERING, BIOMEDICAL
Sunghak Choi, Bong Su Kang, Geonjun Choi, Minsu Kang, Haena Park, Nahyun Kim, Pahn–Shick Chang, Moon Kyu Kwak, Hoon Eui Jeong, Ho-Sup Jung
{"title":"采用批处理-微流控混合方法制备具有增强单分散性和封装效率的多腔PLGA微颗粒","authors":"Sunghak Choi,&nbsp;Bong Su Kang,&nbsp;Geonjun Choi,&nbsp;Minsu Kang,&nbsp;Haena Park,&nbsp;Nahyun Kim,&nbsp;Pahn–Shick Chang,&nbsp;Moon Kyu Kwak,&nbsp;Hoon Eui Jeong,&nbsp;Ho-Sup Jung","doi":"10.1002/anbr.202300044","DOIUrl":null,"url":null,"abstract":"<p>Microparticles with multiple internal chambers hold great promise as drug delivery systems due to their ability to sustain the release of drugs with short half-lives. However, conventional batch methods used for their fabrication have limitations in terms of encapsulation efficiency and particle size distributions, while microfluidic methods suffer from low production efficiency. Herein, a batch-microfluidic hybrid method is presented for fabricating poly(DL-lactic-<i>co</i>-glycolic acid) (PLGA) polymeric microparticles with uniformly distributed, multiple inner microchambers. A scalable batch method is utilized for primary water-in-oil (W/O) emulsions, combined with a precise microfluidic approach for generating controlled secondary emulsions. This approach results in highly uniform PLGA microparticles with tunable size and improved encapsulation efficiency. Additionally, the effect of polydopamine-based surface hydrophilic modification of microfluidic channels on drug encapsulation efficiency is investigated, achieving an efficiency of approximately 85%. The prepared multichamber PLGA microparticles exhibit an extended-release profile without initial burst release, demonstrating their potential for sustained drug delivery in various biomedical applications.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"3 10","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300044","citationCount":"0","resultStr":"{\"title\":\"Multichamber PLGA Microparticles with Enhanced Monodispersity and Encapsulation Efficiency Fabricated by a Batch-Microfluidic Hybrid Approach\",\"authors\":\"Sunghak Choi,&nbsp;Bong Su Kang,&nbsp;Geonjun Choi,&nbsp;Minsu Kang,&nbsp;Haena Park,&nbsp;Nahyun Kim,&nbsp;Pahn–Shick Chang,&nbsp;Moon Kyu Kwak,&nbsp;Hoon Eui Jeong,&nbsp;Ho-Sup Jung\",\"doi\":\"10.1002/anbr.202300044\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Microparticles with multiple internal chambers hold great promise as drug delivery systems due to their ability to sustain the release of drugs with short half-lives. However, conventional batch methods used for their fabrication have limitations in terms of encapsulation efficiency and particle size distributions, while microfluidic methods suffer from low production efficiency. Herein, a batch-microfluidic hybrid method is presented for fabricating poly(DL-lactic-<i>co</i>-glycolic acid) (PLGA) polymeric microparticles with uniformly distributed, multiple inner microchambers. A scalable batch method is utilized for primary water-in-oil (W/O) emulsions, combined with a precise microfluidic approach for generating controlled secondary emulsions. This approach results in highly uniform PLGA microparticles with tunable size and improved encapsulation efficiency. Additionally, the effect of polydopamine-based surface hydrophilic modification of microfluidic channels on drug encapsulation efficiency is investigated, achieving an efficiency of approximately 85%. The prepared multichamber PLGA microparticles exhibit an extended-release profile without initial burst release, demonstrating their potential for sustained drug delivery in various biomedical applications.</p>\",\"PeriodicalId\":29975,\"journal\":{\"name\":\"Advanced Nanobiomed Research\",\"volume\":\"3 10\",\"pages\":\"\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2023-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300044\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Nanobiomed Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202300044\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202300044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

具有多个内腔的微粒作为药物递送系统具有很大的前景,因为它们能够在短半衰期内维持药物的释放。然而,用于制造它们的传统分批方法在封装效率和粒度分布方面具有局限性,而微流体方法的生产效率较低。本文提出了一种批量-微流体混合方法,用于制备具有均匀分布的多个内部微腔的聚(DL-乳酸-共-乙醇酸)(PLGA)聚合物微粒。可扩展的分批法用于油包水(W/O)初级乳液,结合精确的微流体方法产生受控的次级乳液。这种方法产生了具有可调尺寸和改进的封装效率的高度均匀的PLGA微粒。此外,还研究了基于聚多巴胺的微流体通道表面亲水性修饰对药物包封效率的影响,实现了约85%的包封效率。所制备的多室PLGA微粒表现出延长的释放特性,没有初始的突释,证明了其在各种生物医学应用中持续给药的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Multichamber PLGA Microparticles with Enhanced Monodispersity and Encapsulation Efficiency Fabricated by a Batch-Microfluidic Hybrid Approach

Multichamber PLGA Microparticles with Enhanced Monodispersity and Encapsulation Efficiency Fabricated by a Batch-Microfluidic Hybrid Approach

Microparticles with multiple internal chambers hold great promise as drug delivery systems due to their ability to sustain the release of drugs with short half-lives. However, conventional batch methods used for their fabrication have limitations in terms of encapsulation efficiency and particle size distributions, while microfluidic methods suffer from low production efficiency. Herein, a batch-microfluidic hybrid method is presented for fabricating poly(DL-lactic-co-glycolic acid) (PLGA) polymeric microparticles with uniformly distributed, multiple inner microchambers. A scalable batch method is utilized for primary water-in-oil (W/O) emulsions, combined with a precise microfluidic approach for generating controlled secondary emulsions. This approach results in highly uniform PLGA microparticles with tunable size and improved encapsulation efficiency. Additionally, the effect of polydopamine-based surface hydrophilic modification of microfluidic channels on drug encapsulation efficiency is investigated, achieving an efficiency of approximately 85%. The prepared multichamber PLGA microparticles exhibit an extended-release profile without initial burst release, demonstrating their potential for sustained drug delivery in various biomedical applications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advanced Nanobiomed Research
Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-
CiteScore
5.00
自引率
5.90%
发文量
87
审稿时长
21 weeks
期刊介绍: Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信